MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.1B
P/E Ratio
N/A
Total Cash
717.58M
Projected Growth
N/A
Total Debt
21.1M
Revenue
302K
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
8.81
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
VRDN
Capitalization
1.11B
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
718M
Total Cash/Share
8.81
Total Debt
21.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
302K
ROE
N/A
Book Value
483M
P/B Ratio
2.29
Cash Flow
N/A
Earnings
-3.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
810K
Current Ratio
15.43
Current Revenue Per Employee
503.50
Dividends Per Share - Security
N/A
EBITDA
-266.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
8.47
Revenue To Assets
-43.79
Shares Held By Institutions
2.34B
Shares Outstanding - Current
81.5M
Total Liabilities
70.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-29.577
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com